Page last updated: 2024-09-04

allotrap and Colitis

allotrap has been researched along with Colitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boismenu, R; Buelow, R; Chen, Y; Chou, K; El-Sheikh, A	1
Bourreille, A; Buelow, R; de la Blétière, DR; Doubremelle, M; Galmiche, JP; Segain, JP; Toquet, C	1

Trials

1 trial(s) available for allotrap and Colitis

Article	Year
RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:5 Topics: Adolescent; Adult; Aged; Animals; Anti-Inflammatory Agents; Colitis; Crohn Disease; Female; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Interleukin-1; Intestinal Mucosa; Male; Middle Aged; Models, Animal; Peptides; Prospective Studies; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2003

Article

Year

RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.

Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:5

Topics: Adolescent; Adult; Aged; Animals; Anti-Inflammatory Agents; Colitis; Crohn Disease; Female; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Interleukin-1; Intestinal Mucosa; Male; Middle Aged; Models, Animal; Peptides; Prospective Studies; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2003

Other Studies

1 other study(ies) available for allotrap and Colitis

Article	Year
Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis. Annals of the rheumatic diseases, 2002, Volume: 61 Suppl 2 Topics: Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Division; Colitis; Dextran Sulfate; Epithelial Cells; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peptides; Tumor Necrosis Factor-alpha	2002

Article

Year

Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis.

Annals of the rheumatic diseases, 2002, Volume: 61 Suppl 2

Topics: Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Division; Colitis; Dextran Sulfate; Epithelial Cells; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peptides; Tumor Necrosis Factor-alpha

2002